Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Top Cited Papers
- 28 June 2018
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 131 (26), 2877-2890
- https://doi.org/10.1182/blood-2018-03-839753
Abstract
Rosai-Dorfman-Destombes disease (RDD) is a rare non–Langerhans cell histiocytosis characterized by accumulation of activated histiocytes within affected tissues. RDD, which now belongs to the R group of the 2016 revised histiocytosis classification, is a widely heterogeneous entity with a range of clinical phenotypes occurring in isolation or in association with autoimmune or malignant diseases. Recent studies have found NRAS, KRAS, MAP2K1, and ARAF mutations in lesional tissues, raising the possibility of a clonal origin in some forms of RDD. More than 1000 reports have been published in the English literature; however, there is a lack of consensus regarding approach for the clinical management of RDD. Although in most cases RDD can be observed or treated with local therapies, some patients with refractory or multifocal disease experience morbidity and mortality. Here we provide the first consensus multidisciplinary recommendations for the diagnosis and management of RDD. These recommendations were discussed at the 32nd Histiocyte Society Meeting by an international group of academic clinicians and pathologists with expertise in RDD. We include guidelines for clinical, laboratory, pathologic, and radiographic evaluation of patients with RDD together with treatment recommendations based on clinical experience and review of the literature.This publication has 103 references indexed in Scilit:
- Steroid-Resistant Extranodal Rosai-Dorfman Disease of Cheek Mass and Ptosis Treated with Radiation TherapyCase Reports in Hematology, 2013
- Fine needle aspiration diagnosis of Rosai-Dorfman Disease involving thyroidJournal of Cytology, 2012
- Isolated intracranial Rosai-Dorfman disease mimicking meningioma in a child: a case report and review of the literatureThe British Journal of Radiology, 2011
- Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare casesLaboratory Investigation, 2010
- Dramatic efficiency of pegylated interferon in sinus histiocytosis with massive lymphadenopathyBritish Journal of Dermatology, 2010
- Rosai-Dorfman disease of the colon presented as small solitary polypoid lesionRare Tumors, 2010
- Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial Rosai-Dorfman DiseasePLoS Genetics, 2010
- Regression of intracranial Rosai–Dorfman disease following corticosteroid therapyJournal of Neurosurgery, 2006
- Venorelbine and methotrexate for the treatment of Rosai-Dorfman diseasePediatric Blood & Cancer, 2005
- Isolated Rosai—Dorfman disease of the fourth ventricleJournal of Neurosurgery, 2000